Renal pro-inflammatory cytokine gene expression in diabetic nephropathy:: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration

被引:187
|
作者
Navarro, Juan F.
Milena, Francisco J.
Mora, Carmen
Leon, Candelaria
Garcia, Javier
机构
[1] Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, ES-38010 Tenerife, Spain
[2] Hosp Univ Nuestra Senora Candelaria, Res Unit, ES-38010 Tenerife, Spain
[3] Hosp Univ Nuestra Senora Candelaria, Clin Biochem Serv, ES-38010 Tenerife, Spain
[4] Spanish Natl Res Council, Madrid, Spain
关键词
angiotensin II; diabetic nephropathy; enalapril; interleukin; 1; 6; pentoxifylline; tumor necrosis factor-alpha;
D O I
10.1159/000098004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have shown a role for inflammation in the pathogenesis of diabetic nephropathy (DN). Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 and IL-6 are cytokines with a prevalent pro-inflammatory activity. Our objective was to study the renal gene expression of TNF-alpha, IL-1 and IL-6 in DN and their relationship with renal damage assessed by urinary albumin excretion (UAE). In addition, we also investigated the effect of angiotensin-converting enzyme inhibition and pentoxifylline (PTF) administration on these parameters. Methods: After streptozotocin-induced diabetes, rats received either no treatment or therapy with enalapril (EN) or PTF for 8 weeks. Renal expression of proinflammatory cytokines was evaluated by real-time polymerase chain reaction. Urinary cytokine excretion and albuminuria were also evaluated. Results: Renal cortical mRNA expression for TNF-alpha, IL-1 and IL-6 in untreated diabetic rats was 2.4-, 1.2- and 3.4-fold higher than in non-diabetic rats. Kidney weight and UAE were significantly associated with renal mRNA expression of TNF-alpha and IL-6. Both EN and PTF administration virtually abrogated the overexpression of TNF-alpha, IL-1 and IL-6, which was associated with a reduction in kidney weight and urinary albumin excretion. Conclusion: The renal expression of the main pro-inflammatory cytokines TNF-alpha, IL-1 and IL-6 is increased in DN, which is significantly associated with UAE. EN and PTF administration prevented this enhanced expression, leading to a decrease in urinary cytokine excretion and a reduction in albuminuria. These findings provide novel insight into the pathogenic mechanisms of DN, supporting the hypothesis that inflammatory mechanisms play a role in the renal injury secondary to diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [1] Proinflammatory cytokine gene expression in diabetic nephropathy.: Effect of angiotensin-converting enzyme inhibition
    Navarro, J
    Milena, F
    Mora, C
    León, C
    Claverie, F
    Flores, C
    García, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V234 - V235
  • [2] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY
    LEWIS, EJ
    HUNSICKER, LG
    BAIN, RP
    ROHDE, RD
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20): : 1456 - 1462
  • [3] Deleterious effect of a deletion polymorphism in angiotensin-converting enzyme gene on progress on of diabetic nephropathy during angiotensin-converting enzyme inhibition
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Cambien, F
    Lecerf, L
    Poirier, O
    Parving, HH
    DIABETOLOGIA, 1996, 39 : 1133 - 1133
  • [4] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND DIABETIC NEPHROPATHY
    BEAUFILS, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S33 - S38
  • [5] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN DIABETIC NEPHROPATHY
    BREYER, JA
    HUNSICKER, LG
    BAIN, RP
    LEWIS, EJ
    KIDNEY INTERNATIONAL, 1994, 45 : S156 - S160
  • [6] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN DIABETIC NEPHROPATHY
    PARVING, HH
    JOURNAL OF HUMAN HYPERTENSION, 1989, 3 : 117 - 117
  • [7] Angiotensin-converting enzyme inhibition in type I diabetic nephropathy
    Lewis, EJ
    PROGRESSION OF CHRONIC RENAL DISEASES, 1996, 118 : 206 - 213
  • [8] Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
    Tikellis, C
    Johnston, CI
    Forbes, JM
    Burns, WC
    Burrell, LM
    Risvanis, J
    Cooper, ME
    HYPERTENSION, 2003, 41 (03) : 392 - 397
  • [9] Role of angiotensin-converting enzyme (ACE) gene polymorphism and antiproteinuric effect of ACE inhibition in diabetic nephropathy
    Rossing, K
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Parving, HH
    DIABETOLOGIA, 1996, 39 : 1132 - 1132
  • [10] Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice
    Campbell, DJ
    Alexiou, T
    Xiao, HD
    Fuchs, S
    McKinley, MJ
    Corvol, P
    Bernstein, KE
    HYPERTENSION, 2004, 43 (04) : 854 - 859